UAE Pacemaker Market to grow with a CAGR of 3.52%
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Pacemaker Market.
According to TechSci Research report, “UAE
Pacemaker Market Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Pacemaker Market has valued at USD
48.07 million in 2022 and is anticipated to witness an impressive growth in the
forecast period with a CAGR of 3.52% through 2028. This can be due to collaborations and
partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
The rise in disposable income is a
significant driver for the demand in the UAE Pacemaker Market. With higher disposable income,
individuals are more likely to afford expensive medical treatments, including
pacemaker implantation. This increased affordability can lead to a higher
demand for pacemakers as more people can access and afford these advanced
medical devices. Individuals with higher disposable incomes may have a greater
preference for advanced and specialized healthcare services. Pacemakers are sophisticated
medical devices that fall into this category, and the demand for such services
is likely to increase with higher disposable income. Individuals with higher
incomes often have comprehensive health insurance coverage. This, coupled with
increased disposable income, makes elective medical procedures, such as
pacemaker implantation, more feasible. Insurance coverage can play a crucial role
in making these procedures accessible to a broader.
Patients with higher disposable incomes
may prefer the latest and most advanced pacemaker technologies. This can drive
the demand for newer models and features, stimulating innovation in the market.
Pacemakers and their implantation procedures can be expensive. Increased
disposable income reduces financial barriers for patients, making them more
willing to invest in their health and well-being. Individuals with higher
disposable incomes may prioritize maintaining a high quality of life.
Pacemakers can significantly improve the quality of life for individuals with
heart rhythm disorders, making them more willing to invest in such medical
interventions.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Pacemaker Market.”
In February 2023, Sheikh
Shakhbout Medical City (SSMC), one of the largest hospitals in the UAE
specializing in serious and complex care, achieved a milestone by successfully
conducting a leadless cardiac pacemaker procedure for the treatment of a
Emirati patient. This significant case utilized cutting-edge technology
recently sanctioned by the US Food and Drug Administration (FDA) in 2022. The
advanced pacing system addresses the patient's bradycardia, a condition
characterized by a slow heart rhythm, by generating electrical pulses that
stimulate the heart to beat at a normal rate. The FDA-approved device was
implanted through a minimally invasive procedure, avoiding the need for a
surgical incision. Instead, it was introduced through a tube inserted into a
blood vessel in the groin and connected to the heart.
Demographic
changes present challenges in the UAE Pacemaker Market. As the
population ages, there is a higher likelihood of individuals developing
cardiovascular issues that may require pacemakers. An aging demographic often
means a higher prevalence of conditions such as bradycardia, atrial
fibrillation, and heart block. Demographic changes can lead to shifts in
disease patterns. In the context of pacemakers, an aging population may
experience an increased incidence of heart rhythm disorders, contributing to a
higher demand for pacemakers. The aging demographic places additional demands
on healthcare resources, including cardiac care services. Allocating resources
to meet the needs of an aging population, including access to pacemaker
treatments, becomes a challenge. Demographic changes may be associated with an
increase in the prevalence of comorbidities, such as diabetes and hypertension.
These conditions can contribute to cardiovascular issues, further driving the
demand for pacemakers.
UAE Pacemaker Market is
segmented based on Material Type, Technology, Product Type, Application, End
User, and by region.
Based on the Application,
UAE Pacemaker Market is segmented into Arrythmias, Congestive Heart Failure,
Others. Arrhythmias are irregular heart rhythms or abnormal heartbeats that can
occur when the electrical impulses controlling the heartbeat are disrupted. The
heart's electrical system is responsible for coordinating the contraction of
the heart muscle chambers (atria and ventricles), and any disturbance in this
system can lead to arrhythmias. Arrhythmias can range from harmless to
life-threatening, and they may occur in the atria (upper chambers) or
ventricles (lower chambers) of the heart. Tachycardia refers to a faster-than-normal
heartbeat. It can originate in the atria (supraventricular tachycardia) or the
ventricles (ventricular tachycardia). Tachycardias can cause palpitations,
dizziness, and, in severe cases, lead to fainting or cardiac arrest.
Based on Region, Abu Dhabi region held the largest share
in the UAE Pacemaker Market.
Government initiatives and
policies, particularly in the capital city, may prioritize the advancement of
healthcare services. This could include investments in medical infrastructure,
training programs, and the adoption of the latest medical technologies. The
population density and demographics of Abu Dhabi may contribute to a higher
prevalence of cardiovascular diseases, necessitating a greater demand for
pacemakers. Abu Dhabi is a medical tourism hub, individuals from within the UAE
and abroad may travel to the city for specialized medical procedures, including
pacemaker implantation, further boosting the demand in the region.
Some of the major companies operating in
the UAE Pacemaker
Market include:
- Medtronic
Meta FZ-LLC
- Boston
Scientific Corporation UAE
- Abbott
Laboratories, S.A.
- GE
Healthcare UAE
- BIOTRONIK,
UAE
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Pacemaker.
The growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the UAE Pacemaker
Market in the forecast period," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
UAE Pacemaker Market by Type
(Implantable, External), By Technology (Single Chamber, Dual Chamber,
Biventricular Chamber), By Product Type (Conventional, MRI Compatible), By
Application (Arrythmias, Congestive Heart Failure, Others), By End User
(Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Pacemaker Market and provides statistics & information on market size, structure,
and future market growth. The report intends to provide innovative market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in UAE Pacemaker Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com